|
Thursday 26th February 2026 |
Text too small? |
Truscreen Group Limited (NZX/ASX: TRU) (TruScreen or the Company), a global provider of AI enabled products, today provides updated revenue and earnings guidance for the financial year ending 31 March 2026 (FY2026).
FY2026 revenue guidance
• FY2026 product sales revenue is expected to be approximately NZ$2.4 million, representing an increase of 41% on FY2025, but below the market guidance of NZ$2.8 million .
• The variance is primarily due to;
• While a signed sales contract was received from Uzbekistan, the Company is still waiting for payment to be received prior to shipment.
• a delay in the validation programme in Zimbabwe, which has deferred the anticipated second order of 10,000 SUS units into FY2027.
• Total revenue for FY2026 is expected to be approximately NZ$2.7 million, an increase of around 28% on FY2025.
FY2026 Earnings guidance
• The Group expects to report a result similar to FY2025 a loss of ~NZ$2.2 million, reflecting additional market access development costs. The Australian Research & Development tax refund offset is expected to be NZ$200,000 lower than FY2025 from reduced R&D expenditure.
• During FY2026, TruScreen has invested in expanding its distributor network and market presence in Uzbekistan, India, Indonesia and selected African markets. These investments are intended to build the critical mass of product adoption and market access required to support the Company’s path to sustainable profitability over the medium term. The recent publication of the 15,000 patients over 4 years clinical study by COGA (Chinese Obstetricians and Gynaecologists Association) has provided positive interest in our AI enable TruScreen technology.
The Board considers that providing updated quantitative guidance, together with the key underlying assumptions and drivers, is important to ensure the market is kept informed in accordance with the Company’s continuous disclosure obligations.
This announcement has been approved for release by the Board of TruScreen Group Limited.
Ends
No comments yet
MEE - Me Today announces six-month results to 31 December 2025
HGH - Heartland announces 1H2026 result
BRW - FY26 Half Year Results Announcement
February 25th Morning Report
Genesis completes NZ$100m Placement
MCY - Invests heavily in renewables; delivers strong performance
PFI Announces Interim Results
February 24th Morning Report
THL - FY26 Interim Results: underlying NPAT up 11%, 3cps dividend
FPH updates FY26 revenue and earnings guidance